skip to main content
Primo Search
Search in: Busca Geral

Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter

Vanzetto, S. ; Alberto, V. ; Conti, D. ; Macellaro, M. ; Benatti, B. ; Daddario, C. ; Bellia, F. ; Dell’Osso, B.

EUROPEAN PSYCHIATRY, 2021-04, Vol.64 (S1), p.S124-S124 [Periódico revisado por pares]

Paris: Cambridge University Press

Texto completo disponível

Citações Citado por
  • Título:
    Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter
  • Autor: Vanzetto, S. ; Alberto, V. ; Conti, D. ; Macellaro, M. ; Benatti, B. ; Daddario, C. ; Bellia, F. ; Dell’Osso, B.
  • Assuntos: Abstract ; Biomarkers ; Epigenetics ; genetics ; Medicin och hälsovetenskap ; Molecular Neurobiology ; Neuroscience in Psychiatry ; Neuroses ; Obsessive compulsive disorder ; Oral Communications
  • É parte de: EUROPEAN PSYCHIATRY, 2021-04, Vol.64 (S1), p.S124-S124
  • Descrição: Introduction Several evidence recognizes Brain Derived Neurotrophic Factor (BDNF) as a promising biomarker in the pathophysiology of psychiatric disorders, including Obsessive-Compulsive Disorder (OCD), considering the involvement of epigenetic regulation in BDNF altered expression. Objectives This study aims to investigate, in a sample of OCD patients, the epigenetic modulation in terms of levels of methylation and hydroxymethylation on the BDNF gene exon I promoter. Methods Fifty OCD patients, recruited from Psychiatry Unit 2, Sacco University Hospital in Milan and fifty healthy controls, comparable by age and gender. Saliva samples were collected by oral swab and epigenetic analysis were performed at the University of Teramo. Statistical analyses were performed with t test with Bonferroni correction. Results Data analysis showed a significant decrease in 5-methyl cytosine levels (5mC) (mean OCD: 1.221%; mean CTRL: 1.784%; p < 0.001) and a significant increase in 5-Hydroxy-methyl cytosine levels (5hmC) (mean OCD: 1.018%; mean CTRL: 0.527% p< 0.0001) in BDNF gene exon I promoter of OCD patients compared to controls. Regarding 5mC of site 3 and 5hmC of site 1 and 2 of the exon I promoter CpG islands, no statistical significance was found. Conclusions Present results showed significant differences in epigenetic modulation of BDNF gene, which might not be univocally interpreted. They could represent an intrinsic OCD characteristic or the effect of antidepressant drugs, assumed by all recruited patients. Further studies, comparing OCD subjects in treatment vs drug-free, are necessary to define BDNF epigenetic modulation role and its possible use as biomarker in the characterization of OCD. Disclosure No significant relationships.
  • Editor: Paris: Cambridge University Press
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.